• 17␤-Estradiol and testosterone significantly increased the neural cell proliferation.
Introduction
It has been reported that verbal memory declines with the loss of estrogen production in elderly women and the memory loss can be prevented by estrogen replacement therapy (ERT) at the early Abbreviations: BDNF, brain-derived neurotrophic factor; p75NTR, p75 neurotrophin receptor; TrkB, tyrosine kinase receptors B; LTP, long-term potentiation; NGF, neurotrophic growth factor; DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethyl sulfoxide; RT-PCR, reverse transcription polymerase chain reaction.
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Tel.: +86 20 83827812x10077; fax: +86 20 83827712. E-mail addresses: meixpan@yahoo.com.cn, meixpan@gmail.com (M. Pan), zhangcx3@mail.sysu.edu.cn (C. Zhang). state of menopause [7] . It has also been reported that early ERT in post-menopause women may reduce the risk of Alzheimer's disease [27] . In both elderly men and women the risk of Alzheimer's disease increases with age [11] , and the decline in androgen levels and subsequently diminishing of estrogen in elderly men has been suggested to contribute to the age-associated memory loss [3] .
It has been proposed that estrogen may act on central neurons via a direct genomic pathway [24] or indirectly through mitogenactivated protein kinases [20] , cAMP-responsive element binding protein [29] or neurotrophic factors [3] . It was reported that estrogen deprivation in rats reduced brain-derived neurotrophic factor (BDNF) expression, while ERT restored the BDNF level in the brain tissue [3] . BDNF is known to play important role in neuronal growth, survival and plasticity formation [1] . The BDNF/tyrosine kinase receptors B (TrkB) system expresses in the hippocampus region and plays a crucial role in memory acquisition and retention [16] . On the other hand, current studies presumed that testosterone may act through androgen (directly or conversion to dihydrotestosteraone), estrogen (via aromatase conversion) [17] pathways, androgen receptor activation [4] , and increasing neurotrophic growth factor (NGF) levels and induced up-regulation of p75-NGFr in brain in adult male rats [23] . Therefore, testosterone level may account for male's susceptibility to Alzheimer's disease as well as estrogen for female, and the effects of testosterone on hippocampus may be mediated by BDNF expression. In present study, we examined the effects of gonadal hormones on fetal rat hippocampal neural cells proliferation and survival in vitro, BDNF expression, and the subsequent role of BDNF on the neural proliferation.
Materials and methods

Cell culture
Fetal rat hippocumpal neural cells (H19-7/IGF-IR) were purchased from ATCC (No.CRL-2526, USA). The cells were maintained at 34 • C in a humidified atmosphere at 5%CO 2 in phenol-red free Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 200 g/ml geneticin (Sigma), 0.001 mg/ml puromycin (Sigma) and 2 mM l-glutamine (Sigma). For experiments, neural cells were trypsinized with 0.25% trypsin-EDTA, then suspended in complete DMEM and seeded at a density of 3.0 × 10 5 cells/ml in 96-well plate. The cells were cultured to approximately 80% confluence, then the complete DMEM was replaced with FBS-free medium with different concentrations of 17␤-estradiol (E, Sigma) and testosterone (T, Fluca) respectively.
17␤-Estradiol or testosterone was dissolved in pure ethanol with 0.001% ethanol as the final concentration of vehicle in the medium, a concentration without cytoxicity in previous experiments. The cells received treatment of 0.001% ethanol at the final concentration of vehicle in the medium as control group. K252a (Sigma), a selective inhibitor of the tyrosine kinase Trk family of neurotrophin receptors [8] , was dissolved in dimethyl sulfoxide (DMSO, Sigma). 200 nM K252a in DMEM containing 0.01%DMSO was added 2 h prior to the addition of gonadal hormones.
Assessment of cell viability and proliferation
Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, Sigma) colorimetric assay [15] . Briefly, MTT was added to the culture at a final concentration of 0.5 mg/ml and incubated for 4 h. The intracellular purple formazans in living cells were dissolved in lyses buffer (10%SDS, 0.01 M HCl) overnight. The optical density was measured at 595 nm in micro-plate reader (Bio-Rad).
The percentage of 5-bromo-2 -deoxyuridine (BrdU) incorporated cells were determined using BrdU labeling ELISA kit (Roche, USA). BrdU labeling was determined by immunoassay following the manufacturer's instructions. The reaction product was quantified by the measurement of absorbance at 450 nm/655 nm.
Cell cycle analysis by flow cytometry
The cell cycle phase distribution was assessed using flow cytometry. Briefly, the cells were harvested with PBS and re-suspended in chilly 75% ethanol at 4 • C overnight, then incubated in 0.5 ml of staining solution containing 50 g/ml propidium iodide and 50 g/ml RNAase in PBS at 37 • C for 2 h. Approximately 10,000 cells per sample were collected for analysis with EPICS-XL (Beckman). The percentages of cells in each cell cycle phase were calculated using WinMDI v2.8 software. Each sample was tested three times.
Measurement of BDNF protein expression
Cells were harvested in 4 • C PBS and centrifuged for 5 min at 1800 rpm at 4 • C. Cell pellets were sonicated for 20 s at 3 W in 50 l lysis buffer (0.1% (v/v) Triton X-100, 50 mM Tris-HCl (pH 7.0), 200 mM NaCl, 10 mM CaCl 2 , 0.5% NaN 3 , and 1% protease inhibitors cocktail), then centrifuged at 15,000 × g for 30 min at 4 • C. The resulting supernatants were used for measurements of cellular protein [5] and BDNF levels.
Mature BDNF was measured using BDNF-Emax ImmunoAssay System (Promega) following manufacturer's instructions. The cellular concentrations of BDNF in the samples were calculated from the rhBDNF standard curve by linear regression analysis, and expressed as pg/mg protein.
Semi quantification of BDNF mRNA expression
Reverse transcription polymerase chain reaction (RT-PCR) was used to evaluate the expression levels of BDNF mRNA and using GAPDH mRNA as the internal control. Primers specific to BDNF and GAPDH were designed from public sequences using Primer 3 software and the sequences of the PCR primers were as follows: BDNF Sense: 5 TGTGACAGTATTAGCGAGTGGGT 3 , anti-sense: 5 CGATTGGGTAGTTCGGCATT 3 ; GAPDH Sense: 5 AAGTTCAACG-GCACAGTCAAGG 3 , anti-sense 5 GCACCAGTGGATGCAGGGAT 3 .
Total RNA was extracted using TRIzol reagent (Invitrogen), and reverse transcription (RT) reactions were performed in duplicates in SuperScript First-strand Synthesis System (Invitrogen) according to the manufacture's instructions respectively. Conditions of PCR amplification were as follows: BDNF, denaturation at 94 • C for 30 s, annealing at 50 • C for 30 s, extension at 68 • C for 15 s; GAPDH, denaturation at 94 • C for 30 s, annealing at 57 • C for 30 s, extension at 68 • C for 30 s. 5 l of PCR products was resolved by 1% agarose gel electrophoresis, stained with ethidium bromide and visualized under UV light. The density of PCR products was analyzed by Quantity One software (Bio-Rad). Results are expressed as the ratios of BDNF mRNA to GAPDH mRNA from the identical sample.
Statistical analysis
All data are presented as mean ± SEM of two or more repeated independent experiments, and 6-8 replicate per experiment. Statistically significant differences were determined by Student's t-test for two-group comparisons, and by one-way ANOVA followed by Student-Newman-Keuls post hoc analysis for multi-group comparisons. Statistical analyses were performed using SPSS v15.0 (SSPS Inc.). A P value of <0.05 was considered statistically significant.
Results
Gonadal hormones increased cell viability of H19-7/IGF-IR cells
Compared to the control group, treatments with 20, 200 and 2000 nM of 17␤-estradiol for 72 h significantly increased the cell viability in H19-7/IGF-IR cells from 7% to 11% (P < 0.05, F = 8.824, Fig. 1 ). The cell viability of cultures receiving 200 nM or 2000 nM of testosterone was significantly higher than that of control group respectively (P < 0.05, F = 4.478), and the magnitude of the testosterone induced reduction of cell viability ranged from 6% to 8%.
Gonadal hormones promoted H19-7/IGF-IR cells proliferation
To determine whether the increase of cell population is resulted from cell proliferation, the percentage of BrdU incorporated cells in cultures were determined after treatment of 20 nM and 200 nM of 17␤-estradiol and testosterone, respectively. We found that 17␤-estradiol significantly promoted the cell proliferation by around 33% at 20 nM and 36% at 200 nM compared to the control culture , treatments with of 17␤-estradiol (white spotted) for 72 h significantly increased the cell viability from 7% to 11% (P < 0.05). The cell viability of cultures receiving testosterone (gray spotted) was significantly higher than that of control cells respectively (P < 0.05). *: vs control group, P < 0.05.
(P < 0.05, F = 9.457 and F = 9.913, Fig. 2A ). Testosterone significantly promoted cell proliferation by around 25% at 20 nM and 17% at 200 nM (P < 0.05), respectively. The effect of estradiol was more potent than that of testosterone at 200 nM (P < 0.05).
Cell cycle analyses showed that 17␤-estradiol and testosterone elicited an increase in the percentage of hippocampus neural cells in S phase, an essential phase for cell proliferation, at 200 nM 
Gonadal hormones increased BDNF expression
Compared to the control group, BDNF mRNA level in H19-7/IGF-IR cells significantly increased with treatment of 17␤-estradiol for 48 h (P < 0.05, F = 5.425, Fig. 3) , and testosterone for 24 h and 48 h (P < 0.05, F = 7.539, Fig. 3 ), respectively. Compared to the control group, 17␤-estradiol increased cellular BDNF level at 24 h after treatment (P < 0.05, F = 4.327, Fig. 4A ). While testosterone increased cellular BDNF level at 24 h and 48 h after treatment (P < 0.05, F = 5.301, Fig. 4A) . No difference in cellular BDNF expression was observed at 72 h after treatment for any groups. And no difference in supernatant BDNF expression was observed after treatment for any groups (Fig. 4B) .
Effect of Trk receptors inhibitor on gonadal hormones-induced H19-7/IGF-IR cells proliferation
Pre-treatment with K252a, a selective Trk receptors phosphorylation inhibitor, significantly decreased cells proliferation (P < 0.05, t = 3.389, Fig. 5 ), indicating that Trk pathway contributed to the regulation of cell proliferation in these cells. Pre-treatment with K252a blocked the effect of testosterone on cells proliferation (P < 0.05, F = 3.996, Fig. 5 ), suggesting the requirement of Trk receptors activation in testosterone-mediated effects on neural cell proliferation. Pre-treatment with K252a did not abolish the effect of 17␤-estradiol on cell proliferation.
Discussion
The present study demonstrated that 17␤-estradiol and testosterone promoted fetal hippocampal neural cell proliferation and viability. Testosterone and 17␤-estradiol increased the cellular BDNF level and BDNF mRNA expression. Effect of testosterone on the cell proliferation was blocked selective inhibitor of neurotrophin receptor (Trk), suggesting that the effects of testosterone might require neurotrophin receptor activation.
Hippocampal neurogenesis has been reported to involve in the effects of antidepressants [21] , performances on a hippocampal dependent task and recovery from injury [25, 26] . New neurons, since they are structurally plastic, are highly susceptible to changes in the environment and different life experiments [12] . Newly generated cells in the adult mouse hippocampus have neuronal morphology and can display passive membrane properties, action potentials and functional synaptic inputs similar to those found in mature dentate granule cells [26] . It was reported that testosterone analog alone increased the number of BrdU labeled neural stem cell (NSC) in embryonic culture [6] . Ovarian steroids increase the proliferation of granule cell precursors in the dentate gyrus of the adult animals [18, 22] . It was found here that estrogen and testosterone exert effect on promoted proliferation in H19-7/IGF-IR cells using BrdU assay. These results supported the epidemiological studies demonstrated that women using hormone replacement therapy performed significantly better on a visual memory test in a cross-sectional study [13] . In view of roles of hippocampal neurogenesis, it would be important for the neural development and survival in adults. Our findings raised the possibility that effects of gonadal hormones on promoted proliferation and improved viability could help prevention or improvement of neurodegenerative disease.
Neurotrophins are key signaling molecules in the development of the nervous system. They elicit diverse cellular responses such as proliferation, differentiation, survival and apoptosis [10] . Initially synthesized as precursors, neurotrophins are cleaved to produce mature proteins, which promote neural survival and enhance synaptic plasticity by activating Trk receptor tyrosine kinases [2] . It was reported that endogenous produced neurotrophins (BDNF and NT-3) and high-affinity Trk-mediated signaling pathways mediated cortical progenitors and microglial cells survival and neurogenesis [28] . Exogenous BDNF has effects on postsynaptic excitability and Ca 2+ signaling in the dentate granule cell, and the postsynaptic BDNF-TrkB pathway is crucial for regulation of excitatory synaptic transmission and long-term potentiation (LTP) induction, which is an important synaptic connection model of memory formation [14] .
Our data showed that BDNF expression displayed a timedependent increasing in control culture, while estradiol and testosterone had more potent effect on promoting neural cells proliferation compared with the controls. This result indicated that BDNF played an important role in protection and/or reparation on cell model of cytotoxicity and gonadal hormone may have the beneficial effect through enhanced BDNF expression. Testosterone increased BDNF expression [19] and promoted cell growth, differentiation, morphology, survival in center neuronal system [9] , suggested that BDNF might media the effects of gonadal hormones on neural cells proliferation. K252a significantly slowed down the neural cell proliferation in the present study, indicating that Trk receptor also contributed to the hippocampal neural cell proliferation. Additionally, K252a blocked the proliferation promoting activity of testosterone, indicating that activation of Trk receptor was required for testosterone to mediate its effect on hippocampal neural cell proliferation. Therefore, testosterone might enhance hippocampal neurogenesis via directly increased cell proliferation through a neurotrophin receptor activation dependent mechanism. While estradiol may promote cell proliferation through BDNF stimulation and other pathways at the same time.
Gonadal hormones replacement therapy has been proved to be an effective for aging related diseases. Although some discrepancy results have been reported, it is probably that the time point of treatment is important to get a beneficial effect. These results showed an important new lead in the prevention and treatment against neurodegenerative diseases with aging of neurodegenerative diseases.
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